Docus
Founded 2021 · 24 employees on LinkedIn · 2 known investors
Find your way into Docus
Sign up to see every warm intro you have to Docus
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Docus team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Docus provides an AI layer for diagnostic labs, offering clinical interpretation reports, follow-up recommendations, compliance validation, digital requisitions, and context-aware AI assistants for doctors and patients. It serves direct-to-consumer, reference, and in-house/clinic labs with integration via API/HL7 or its own interfaces.
Founders & leadership
Docus was founded in 2021 by Robert Sargsyan and Gevorg Nazaryan.
GN

Gevorg NazaryanCTO & Co-founderGevorg Nazaryan is the founder of Docus, an AI platform for diagnostic labs that generates clinical interpretation reports, follow-up recommendations, compliance validation, and AI assistants for doctors and patients. He has around ten years of experience in technology and product management, including technology architecture and product management roles.
Investors · 2
Formula VClisted by Formula VCYerevan · $100K – $1M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Docus do?
- Docus provides an AI layer for diagnostic labs, offering clinical interpretation reports, follow-up recommendations, compliance validation, digital requisitions, and context-aware AI assistants for doctors and patients. It serves direct-to-consumer, reference, and in-house/clinic labs with integration via API/HL7 or its own interfaces.
- Who founded Docus?
- Docus was founded by Robert Sargsyan, Gevorg Nazaryan in 2021.
- Who are Docus's investors?
- Docus's investors include Formula VC, Triple Ventures.


